Omnio raises €2.9 million to advance its plasminogen-based therapy for chronic wounds. This funding round was oversubscribed and led by existing investors.
Amount Raised
€2.9 Million
Round Type
Seed
Description
Omnio, a Umeå-based BioTech startup, has successfully raised €2.9 million from existing investors to advance its plasminogen-based therapy for hard-to-heal chronic wounds. The funds will help move the therapy closer to clinical studies. This follows a previous €4.3 million financing round to complete its GMP manufacturing process. The CEO expressed confidence in continued investor support for development.
Quick answer
Omnio raised €2.9 Million in a Seed round, dated October 2, 2026. Omnio is based in Umeå, Vasterbottens Lan, Sweden.
- How much did Omnio raise?
- Omnio raised €2.9 Million in a Seed round on October 2, 2026.
- What does Omnio do?
- Omnio is a Umeå-based BioTech startup developing plasminogen-based therapies for chronic wounds and related conditions.
- Where is Omnio based and how big is it?
- Omnio is based in Umeå, Vasterbottens Lan, Sweden. Fundz records about 51 employees.
Source: Fundz verified event record.
Who to call at Omnio, and when
A new round usually means Omnio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Omnio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Omnio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Omnio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Omnio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Omnio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.